Denmark: Northern Horizon expands Danish portfolio with Danish mixed hybrid project
Nordic investment manager Northern Horizon, specialising in social infrastructure, has expanded its Danish portfolio with the acquisition of a new care home development project...
France: Halma strengthens healthcare capabilities with acquisition of Dreampath Diagnostics
UK-listed Halma, a global group of life-saving technology companies, has acquired Dreampath Diagnostics, a France-based specialist in automated workflow solutions for anatomical pathology laboratories.
The...
US: EQT to acquire the TachoSil biosurgery business from Corza Medical
US-based PE firm, GTCR, has agreed for Corza Medical, a US-based global medtech company, to sell its Biosurgery business unit, including the TachoSil product...
France: Five Arrows provides unitranche facility to support Vivo’s investment in Dutscher
Five Arrows, the alternative assets arm of Rothschild & Co, has arranged and provided a unitranche facility to support Vivo Capital’s investment in Dutscher...
UK: Onebright expands clinical services with acquisition of Mindstep
Onebright Group, the UK's largest private outpatient mental healthcare and neurodevelopmental services provider, has acquired Mindstep, a digital mental health platform, creating the UK's...
UK: Clarivate announces sale of Life Sciences & Healthcare segment to Altaris for US$600m
Clarivate, a UK-based, New York-listed global provider of intelligence, has agreed to divest its Life Sciences & Healthcare segment to Altaris, a US-based investment...
Germany: Bredehorst Clinic Medical Management partners with Sigla
European PE firm, Sigla, has invested in Bredehorst Clinic Medical Management (BCMM), a provider of healthcare procurement optimisation services in Germany.
Founded in 2006, BCMM...
Europe: CVC raises €3.0bn for Europe-focused mid-market private equity fund – Catalyst III
CVC Capital Partners has announced the final close of CVC Capital Partners Catalyst III, its European-focused mid-market private equity fund, at approximately €3.0bn (US$3.4bn)...
UK: Novartis agrees to acquire Myricx Bio for up to US$1.5bn
Swiss multinational pharma, Novartis, has agreed to acquire Myricx Bio, a UK-based biotech company developing a new class of ADCs, using N-myristoyltransferase inhibitor (NMTi)...
France: Ipsen adds to late-stage oncology pipeline with acquisition of Kartos Therapeutics
In its second major deal announcement of the week following news of its proposed acquisition of Memo Therapeutics for in excess of €700m, France...
Advertisement
